Group One Trading
SKYE icon

Group One Trading’s Skye Bioscience SKYE Stock Holding History

Group One Trading’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77K Hold
500
– – ﹤0.01% 6943
2026
Q1 		$2.46K Buy
500
+437
+694% +$2.85K ﹤0.01% 6987
2025
Q4 		$375 Sell
63
-212
-77% -$2.48K ﹤0.01% 7838
2025
Q3 		$8.65K Buy
275
+62
+29% +$1.87K ﹤0.01% 7258
2025
Q2 		$7.11K Buy
+213
New +$3.53K ﹤0.01% 6922

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Group One Trading's SKYE Position: Q2 2026 in Review

Group One Trading reduced its Skye Bioscience (SKYE) stake by 36% in Q2 2026, selling an estimated $2.06K and leaving 574 shares worth $3.18K. The position accounts for ﹤0.01% of the portfolio, ranked #6895.

Group One Trading first reported a position in SKYE in Q3 2025 and has held it in 4 quarters since. The position peaked at $13.3K in Q4 2025. 33 funds tracked by Wall St. Rank hold SKYE as of Q2 2026.

  • Group One Trading held 574 shares of Skye Bioscience worth $3.18K as of Q2 2026.
  • Group One Trading sold 327 Skye Bioscience shares in Q2 2026, an estimated $2.06K.
  • Skye Bioscience made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6895 holding.
  • Group One Trading first reported a position in Skye Bioscience in Q3 2025 and has held it in 4 quarters since.
  • Group One Trading's Skye Bioscience position peaked at $13.3K in Q4 2025.
  • 33 funds tracked by Wall St. Rank held Skye Bioscience as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.